Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Philipp Staber"'
Autor:
Peter Valent, Alberto Orfao, Stefan Kubicek, Philipp Staber, Torsten Haferlach, Michael Deininger, Karoline Kollmann, Thomas Lion, Irene Virgolini, Georg Winter, Oliver Hantschel, Lukas Kenner, Johannes Zuber, Florian Grebien, Richard Moriggl, Gregor Hoermann, Olivier Hermine, Michael Andreeff, Christoph Bock, Tariq Mughal, Stefan N. Constantinescu, Robert Kralovics, Veronika Sexl, Radek Skoda, Giulio Superti-Furga, Ulrich Jäger
Publikováno v:
HemaSphere, Vol 5, Iss 3, p e536 (2021)
During the past few years, our understanding of molecular mechanisms and cellular interactions relevant to malignant blood cell disorders has improved substantially. New insights include a detailed knowledge about disease-initiating exogenous factors
Externí odkaz:
https://doaj.org/article/f83af71379764078b058a0d468ded29b
Autor:
Christoph C Zielinski, Markus Kieler, Matthias Unseld, Daniela Bianconi, Fredrik Waneck, Robert Mader, Fritz Wrba, Thorsten Fuereder, Philipp Staber, Walter Berger, Maria Sibilia, Stephan Polterauer, Leonhard Müllauer, Gerald W Prager
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Background High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clin
Externí odkaz:
https://doaj.org/article/a302d32bee064beda7f655065565cb61
Autor:
Patricia Freund, Edit A Porpaczy, Trang Le, Michaela Gruber, Clemens Pausz, Philipp Staber, Ulrich Jäger, Katrina Vanura
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156693 (2016)
The cannabinoid receptors 1 and 2 (CNR1&2) are overexpressed in a variety of malignant diseases and cannabinoids can have noteworthy impact on tumor cell viability and tumor growth. Patients diagnosed with chronic lymphocytic leukemia (CLL) present w
Externí odkaz:
https://doaj.org/article/504113546238463987379eb73e35dd7f
Autor:
Philipp Staber
Publikováno v:
memo - Magazine of European Medical Oncology. 16:1-1
Autor:
Philipp Staber
Publikováno v:
memo - Magazine of European Medical Oncology. 15:3-3
Autor:
Al-Sawaf, O., Robrecht, S., Fink, A., Ritgen, M., Johansson, P., Philipp Staber, Jaeger, U., Niemann, C., Pallasch, C., Kreuzer, K., Stilgenbauer, S., Fischer, K., Wendtner, C., Hallek, M., Eichhorst, B.
Publikováno v:
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1a2281af70e7dce8d0ce9cd7a906ef12
Autor:
Georg, Hopfinger, Philipp, Staber
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 144(20)
NEW WHO CLASSIFICATION 2016 FOR LYMPHOMA AND MOLECULAR MARKER: The new WHO 2016 Classification for Lymphomas included more detailed definitions of individual entities, such as: the Anaplastic Large Cell Lymphoma, ALK; the terminus of enteropathy-asso
Autor:
A.Prof. Philipp Staber
Publikováno v:
memo - Magazine of European Medical Oncology. 8:176-179
The Annual Meeting of the American Society of Hematology (ASH) 2014 has highlighted a number of spectacular advances of the past couple of years for T cell lymphomas. These lymphomas are probably the most challenging of all types of hematologic malig
Autor:
Marius E, Mayerhoefer, Markus, Raderer, Ulrich, Jaeger, Philipp, Staber, Barbara, Kiesewetter, Daniela, Senn, Ferdia A, Gallagher, Kevin, Brindle, Edit, Porpaczy, Michael, Weber, Dominik, Berzaczy, Ingrid, Simonitsch-Klupp, Christian, Sillaber, Cathrin, Skrabs, Alexander, Haug
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose To determine whether, in patients with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL), [18F]FDG PET/MR can capture treatment effects within the first week after treatment initiation, and whether changes in glucose metabolism and cell den